论文部分内容阅读
单纯应用放疗治疗肺癌虽为数极多,但应用临床病理资料预测疗效报道者甚少。罗切斯特大学癌瘤中心放射科治疗肺癌200例,男157例,女43例。临床Ⅰ期3例(1.5%),Ⅱ期22例(11%),Ⅲ期75例(37.5%)及Ⅳ期100例(50%)。Ⅰ期为限于肺野内之肿物,最长径在3厘米以内,肿物远距叶支气管。Ⅱ期为伴有同侧肺门转移,或肿瘤大于3厘米,或伴有肺不张或阻塞性肺炎但无胸水,肿瘤边缘距隆突至少2厘米,肺门可有或无肿大淋巴
Although the use of radiotherapy alone in the treatment of lung cancer is very numerous, there are very few reporters who use clinical pathological data to predict efficacy. The Department of Radiology at the Cancer Center of the University of Rochester treats 200 patients with lung cancer, including 157 males and 43 females. Clinical stage I was 3 cases (1.5%), stage II was 22 cases (11%), stage III was 75 cases (37.5%) and stage IV was 100 cases (50%). Phase I is limited to tumors in the lung field with a longest diameter of less than 3 cm and a distant leaf bronchus. Stage II is associated with ipsilateral hilar metastasis, or tumors greater than 3 cm, or with atelectasis or obstructive pneumonia but without pleural effusion, at least 2 cm from the edge of the tumor at the tumor margin, and hilar lymph node with or without lymphadenopathy